Literature DB >> 18528462

Severe congenital neutropenia: genetics and pathogenesis.

Laurence A Boxer1.   

Abstract

Severe congenital neutropenia (SCN) is a rare hematological disease characterized by a selective decrease in circulating neutrophils, bone marrow maturation arrest at the promyelocyte stage, and occurrence of infections. Studies of SCN patients revealed impaired proliferative characteristics and accelerated apoptosis of bone marrow progenitor cells. Sequencing analysis indicated a heterozygous deletion or substitution mutations in the neutrophil elastase (NE gene) in many patients. Expression of NE mutants but not normal NE accelerated apoptosis of human HL-60 progenitor cells similar to that seen with actual patient cells. Our data indicate that impaired survival of bone marrow myeloid progenitor cells arises from expression of mutant NE which contributes to neutropenia in SCN. In an unusual clinical set of studies during which SCN developed in five children from four families impregnated by the same sperm donor, we identified the responsible donor by employing genomic DNA studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18528462      PMCID: PMC1500938     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  25 in total

1.  Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia.

Authors:  A A Aprikyan; W C Liles; E Rodger; M Jonas; E Y Chi; D C Dale
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

2.  Congenital agranulocytosis: prolonged survival and terminal acute leukemia.

Authors:  P A Gilman; D P Jackson; H G Guild
Journal:  Blood       Date:  1970-11       Impact factor: 22.113

Review 3.  Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias.

Authors:  Melvin H Freedman; Blanche P Alter
Journal:  Semin Hematol       Date:  2002-04       Impact factor: 3.851

Review 4.  Kostmann syndrome and severe congenital neutropenia.

Authors:  Cornelia Zeidler; Karl Welte
Journal:  Semin Hematol       Date:  2002-04       Impact factor: 3.851

5.  Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway.

Authors:  Y Dror; M H Freedman
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

6.  Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b).

Authors:  Taco W Kuijpers; Nikolai A Maianski; Anton T J Tool; G Peter A Smit; Jan Peter Rake; Dirk Roos; Gepke Visser
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

Review 7.  Hereditary neutropenia: dogs explain human neutrophil elastase mutations.

Authors:  Marshall Horwitz; Kathleen F Benson; Zhijun Duan; Feng-Qian Li; Richard E Person
Journal:  Trends Mol Med       Date:  2004-04       Impact factor: 11.951

8.  Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia.

Authors:  Phil J Ancliff; Rosemary E Gale; Michael J Watts; Ri Liesner; Ian M Hann; Stephan Strobel; David C Linch
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia.

Authors:  Andrew A G Aprikyan; Tatyana Kutyavin; Steven Stein; Pavel Aprikian; Elin Rodger; W Conrad Liles; Laurence A Boxer; David C Dale
Journal:  Exp Hematol       Date:  2003-05       Impact factor: 3.084

10.  Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.

Authors:  Christine Bellanné-Chantelot; Séverine Clauin; Thierry Leblanc; Bruno Cassinat; Fernando Rodrigues-Lima; Sandrine Beaufils; Christelle Vaury; Mohamed Barkaoui; Odile Fenneteau; Micheline Maier-Redelsperger; Christine Chomienne; Jean Donadieu
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

View more
  5 in total

Review 1.  Gfi1-cells and circuits: unraveling transcriptional networks of development and disease.

Authors:  James D Phelan; Noah F Shroyer; Tiffany Cook; Brian Gebelein; H Leighton Grimes
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

Review 2.  Hematopoietic stem cell transplantation for severe congenital neutropenia.

Authors:  James A Connelly; Sung W Choi; John E Levine
Journal:  Curr Opin Hematol       Date:  2012-01       Impact factor: 3.284

3.  Gfi1 regulates miR-21 and miR-196b to control myelopoiesis.

Authors:  Chinavenmeni S Velu; Avinash M Baktula; H Leighton Grimes
Journal:  Blood       Date:  2009-03-10       Impact factor: 22.113

4.  Severe congenital cyclic neutropenia: A case report.

Authors:  Vidyavathi H Patil; Shivayogi M Hugar; Girish Balikai; Sudha Patil
Journal:  Int J Appl Basic Med Res       Date:  2016 Oct-Dec

Review 5.  Identification of novel MECOM gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.

Authors:  James A Connelly; Rajen J Mody; Yi-Mi Wu; Dan R Robinson; Robert J Lonigro; Pankaj Vats; Erica Rabban; Bailey Anderson; Kelly Walkovich
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.